Figure 2.
![Twelve-month cumulative incidence of bleeding by cancer type. Other cancers include bone/connective tissues (n = 140), thyroid (n = 61), testicular (n = 42), thymus/heart/mediastinum (n = 24), penis (n = 23), retroperitoneal/peritoneum (n = 19), Kaposi (n = 8), and ocular (n = 6). ∗Cumulative incidence for the entire cohort (cumulative incidence, 8.5% [95% CI, 8.0-9.0]). CML, chronic myelogenous leukemia; NOS, not otherwise specified.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodvth/3/1/10.1016_j.bvth.2025.100116/1/bvth_vth-2025-000394-gr2.jpeg?Expires=1768601405&Signature=vNW9-hv36ic74~EKYAHzVp4gzwT000ICB9wmQE25Kc9YjX8kgzI9OWDu1iEgkUYaAH1KPf8J9zvj7DYKUHxS~lrMJkuEMGPhFWDYJmsy58QBGChv5ypahyiaZYjdU2GbUevNpHXbIN3y2Jx~WiOwPKOF6BxpfCoCu4QzSO-pBQWMA8yEl12cnyyLb3XdDfsYBCjTV9TsIxvhtwogQgcvA71kfPeEPvuYx59FPXJskqKHTEAxLnsu-Y4DtkGMaEWljcL8MKt~OmKby9-CIfUvLe-UEf~jbN7XPd4GLYKqJ95~EEZV~MN~4Wuwboag2CIEBFlFF4VcyDdzFJFK1Sud0A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Twelve-month cumulative incidence of bleeding by cancer type. Other cancers include bone/connective tissues (n = 140), thyroid (n = 61), testicular (n = 42), thymus/heart/mediastinum (n = 24), penis (n = 23), retroperitoneal/peritoneum (n = 19), Kaposi (n = 8), and ocular (n = 6). ∗Cumulative incidence for the entire cohort (cumulative incidence, 8.5% [95% CI, 8.0-9.0]). CML, chronic myelogenous leukemia; NOS, not otherwise specified.
